Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

While treatment for high blood pressure is not associated with falls, there is some evidence to suggest patients who take blood pressure lowering medications may be more likely to faint or suffer kidney problems which lead to hospital admission, finds a study from ARC OxTV supported researchers.

A nurse helping an elderly person to walk down some stairs

Findings from the study, published in the BMJ, showed that patients taking blood pressure lowering treatment for an average of three years had an 18% increased risk of acute kidney injury and a 28% increased risk of syncope (fainting), but there was no link between treatment and falls or fractures.

The meta-analysis included data from 58 randomised controlled trials involving 280,638 participants and aimed to understand whether those on medication to lower their blood pressure were more likely to report a fall or experience other specific side-effects.

High blood pressure is one of the leading risk factors for cardiovascular disease worldwide, and affects half of people aged over 65 in the UK. For those who are frail or have underlying health conditions, clinical guidelines suggest doctors take a personalised approach to prescribing drugs to lower blood pressure, taking into account the risk that their patient may experience side effects like a fall or kidney injury.

While many meta-analyses of existing research studies review the effectiveness of blood pressure-lowering drugs, few have analysed data on their potential harms or looked for specific side effects.

Lead researcher, Dr James Sheppard, from the University of Oxford’s Nuffield Department of Primary Care Health Sciences, said, “Our analysis dispels the widely held belief that blood pressure-lowering drugs are linked to an increase in the risk of experiencing a fall. However, we did show a link between these drugs and the risk of passing out or experiencing sudden kidney problems, which can have a really major impact on an individual’s quality of life. For relatively fit patients, the risk of these side effects is likely to be very small, but for older people living with lots of long term conditions, the potential harms of treatment should be taken into consideration.

"With clinical guidelines around the world increasingly recommending more intensive treatment for high blood pressure, these findings will help doctors to take a more personalised approach to managing the condition, taking into account both the potential benefit of treatment as well as the harms.”

The team included researchers from the Universities of Oxford, Keele, Cambridge, and Bristol, funded by the Wellcome Trust, Royal Society and the National Institute for Health Research School for Primary Care Research.

READ MORE:

Association between antihypertensive treatment and adverse events: systematic review and meta-analysis
Ali Albasri, Miriam Hattle, Constantinos Koshiaris et al
BMJ 2021;372:n189 doi: https://doi.org/10.1136/bmj.n189

Similar stories

Future-Proofing Mental Health

ARC OxTV Mental Health across the Lifecourse theme lead, Professor Cathy Creswell is among a number of UK academics calling, in Journal of Mental Health, for targets for mental health research in order to meet the healthcare challenges of the next decade.

Children and Adolescents’ Mental Health: One Year On

The ARC OxTV supported 'COVID-19 Supporting Parents, Adolescents, and Children in Epidemic (CO-SPACE) study, reports that behavioural, emotional and attentional difficulties in children changed considerably throughout the past year, increasing in times of national lockdown and decreasing as restrictions eased and schools reopened.

New study shows potential link between bodyweight and risk of severe COVID-19, especially for younger adults

The first large study to report the effect of bodyweight on risk of worse outcomes from COVID-19 across the full range of body mass index (BMI) is published today in The Lancet Diabetes and Endocrinology journal.

New clinical prediction tools for myeloma

New research, that further develops findings from CLAHRC Oxford supported research, has led to the development of new clinical prediction models for myeloma that incorporate both symptoms and blood test results.

ARC OxTV theme lead, Professor John Powell appointed NIHR Senior Investigator

ARC OxTV Digital Health theme lead, Professor John Powell joins the NIHR college of senior research leaders.